Open menu

Nanotechnology Business News

The latest product and company news

RSS Subscribe to our Nanotechnology Business News feed

LVEM5 Benchtop Electron Microscope on Display at ICONN 2012

Delong America is pleased to announce that we will have the LVEM5 benchtop electron microscope on display at the 10th Asia-Pacific Microscopy Conference (APMC 10), the 2012 International Conference on Nanoscience and Nanotechnology (ICONN 2012) and the 22nd Australian Conference on Microscopy and Microanalysis (ACMM 22).

Posted: Jan 10th, 2012

Read more

FEI Buys ASPEX Corporation

FEI, a leading instrumentation company providing imaging and analysis systems for research and industry, today announced that it has acquired ASPEX Corporation of Delmont, PA. ASPEX provides rugged scanning electron microscopes (SEMs) and related services for environmentally demanding military, industrial and factory floor applications.

Posted: Jan 9th, 2012

Read more

Intertek Cantox Develops Method to Promote High-Quality Nanotoxicology Studies

Intertek Cantox, a leading provider of scientific and regulatory consulting services to the food, chemical, and pharmaceutical industries, announces the development of a method to promote high quality nanotoxicology studies allowing companies to ensure the safety of nanotechnology and nanomaterials based products entering the market.

Posted: Jan 9th, 2012

Read more

Blend Therapeutics Founded by Leading Researchers in Chemistry and Nanomedicine to Develop a New Class of Integrative Combination Medicines

Blend Therapeutics, a biotechnology company discovering and developing a new class of integrative combination medicines, announced the company's founding and strategic mission to develop innovative combination medicines with novel pharmacological profiles designed to target distinct disease pathways with optimal efficacy and safety.

Posted: Jan 6th, 2012

Read more

Arrowhead Announces FDA Clearance To Initiate Adipotide Phase I Clinical Trial

Arrowhead Research Corporation, a nanomedicine company with development programs in oncology and obesity, today announced that the Investigational New Drug Application (IND) for its first obesity drug candidate, Adipotide, was accepted by the U.S. Food and Drug Administration allowing the initiation of a clinical trial to test the safety of the compound.

Posted: Jan 4th, 2012

Read more